Marco Bocchetti
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 3
- RNA Interference and Gene Delivery 2
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5
- Co-authors
- Michele Caraglia (21 shared papers)Alessia Maria Cossu (15 shared papers)Silvia Zappavigna (11 shared papers)Tarik Regad (4 shared papers)Anna Grimaldi (2 shared papers)Rosanna Filosa (1 shared paper)Giuseppe Andrea Ferraro (1 shared paper)Giovanni Francesco Nicoletti (1 shared paper)
- Journals
- International Journal of Molecular Sciences (8 papers)Journal of Translational Medicine (4 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Pharmaceutics (1 paper)American Journal of Otolaryngology (1 paper)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Marco Bocchetti
29 papers receiving 887 citations
Marco Bocchetti's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 270
- Oncology 180
- Molecular Biology 386
- Neurology 30
- Immunology 76
Countries citing papers authored by Marco Bocchetti
This map shows the geographic impact of Marco Bocchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bocchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bocchetti more than expected).
Fields of papers citing papers by Marco Bocchetti
This network shows the impact of papers produced by Marco Bocchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bocchetti. The network helps show where Marco Bocchetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Bocchetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-Inflammatory Drugs as Anticancer Agents Hit paper breakdown → | 2020 | 302 |
| 2 | 2019 | 157 | |
| 3 | 2019 | 73 | |
| 4 | 2021 | 53 | |
| 5 | 2022 | 46 | |
| 6 | 2022 | 45 | |
| 7 | 2021 | 36 | |
| 8 | 2021 | 35 | |
| 9 | 2020 | 27 | |
| 10 | 2023 | 25 | |
| 11 | 2023 | 17 | |
| 12 | 2022 | 14 | |
| 13 | 2024 | 11 | |
| 14 | 2024 | 9 | |
| 15 | 2020 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2021 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2024 | 5 | |
| 20 | 2023 | 4 |
About Marco Bocchetti
Marco Bocchetti is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 32 papers that have together received 900 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Head and Neck Cancer Studies (3 papers), RNA modifications and cancer (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer Cells and Metastasis (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Cancer Research (270 citations), Oncology (180 citations), Molecular Biology (386 citations), Neurology (30 citations) and Immunology (76 citations). Marco Bocchetti has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Michele Caraglia, Alessia Maria Cossu, Silvia Zappavigna, Tarik Regad, Anna Grimaldi, Rosanna Filosa, Giuseppe Andrea Ferraro, Giovanni Francesco Nicoletti, Marianna Scrima and Amalia Luce. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Translational Medicine, Journal of Experimental & Clinical Cancer Research, Pharmaceutics and American Journal of Otolaryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.